Ferinject 500mg Injection contains Ferric Carboxymaltose, a parenteral iron preparation used to treat iron deficiency anemia when oral iron therapy is ineffective or cannot be used. It provides a rapid and effective replenishment of iron stores in patients with conditions such as chronic kidney disease, postpartum anemia, or iron deficiency due to gastrointestinal disorders. Ferric Carboxymaltose is a stable complex that allows controlled release of iron, minimizing free iron toxicity and enabling administration of high doses in a single infusion. This helps improve hemoglobin levels and restore iron balance efficiently. Ferinject is typically administered intravenously under medical supervision, with dosage and frequency tailored to the patient’s iron requirements and clinical condition. Common side effects may include mild injection site reactions, headache, dizziness, or nausea, but serious adverse effects are rare when used appropriately. It is contraindicated in patients with known hypersensitivity to Ferric Carboxymaltose or any of its components, and caution is advised in those with iron overload disorders. Ferinject 500mg Injection is a valuable therapeutic option for rapid correction of iron deficiency anemia, improving patient quality of life and reducing the need for blood transfusions.